
Bioregulators
Vesugen
Vesugen is the synthetic tripeptide Lys-Glu-Asp (KED). It is one of the short peptides studied mainly by the St. Petersburg Institute of Bioregulation and Gerontology group, which describes it as a vascular peptide.
- Container
- Glass vial, crimp seal, flip-top cap
- Storage
- -20 °C, desiccated
- Paperwork
- Lot certificate (HPLC + mass spec) shown before you pay
Lot certificates
You’ll see American Peptides on the lab’s copy. They’re our supplier.
- 20 mg, lot VESU20-0528: 99.90% purity (RP-HPLC), 20.64 mg measured, identity confirmed by mass spec. Issued 2026-06-17 by Bioviridian Inc.. Verify certificate COA4865
Our vials are filled from lots made by our supplier, American Peptides, and tested by Bioviridian Inc.The laboratory’s original certificate lists American Peptides as the vendor. Look up the code at bioviridians.com to check it.
What researchers study it for
- Vascular endothelial cell cultures
- Neuronal differentiation of stem cells
- Alzheimer's disease cell models
- Aging of cultured fibroblasts
How it is thought to work
The mechanism is not established. Cell-culture studies report changes in proliferation and differentiation markers such as Ki-67, nestin and GAP43. A 2024 study found more dendrite branching in induced neurons but no effect on mitochondria, lysosomes or p16. The group proposes direct peptide binding to gene promoters, based largely on computer docking.
Where the research stands
Mainly preclinical; small Russian human studies. Human data are limited to small studies in Russian-language journals, including a before-and-after study of 41 patients. Nearly all work involves one research group. No trials were found on ClinicalTrials.gov and no FDA-approved product was found.
Sources
- Khavinson VKh, et al. (2012). Peptides tissue-specifically stimulate cell differentiation during their aging. Bulletin of Experimental Biology and Medicine.
- Khavinson VK, Lin'kova NS, Umnov RS. (2021). Peptide KED: Molecular-Genetic Aspects of Neurogenesis Regulation in Alzheimer's Disease. Bulletin of Experimental Biology and Medicine.
- Kraskovskaya N, et al. (2024). Short Peptides Protect Fibroblast-Derived Induced Neurons from Age-Related Changes. International Journal of Molecular Sciences.
- Kitachev KV, et al. (2014). [The efficacy of peptide bioregulators of vessels in lower limbs chronic arterial insufficiency treatment in old and elderly people]. Advances in Gerontology (Uspekhi Gerontologii).
Read more
For laboratory research use only. Not a drug, food, supplement or cosmetic; not for human or veterinary use. Nothing on this page is medical advice or a usage guide.
